← Open Payments lookup

WILLIAM CHAMBERLAIN: Open Payments

NPI 1760857247 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$241 in 14 payments from 10 companies in 2025. Trend: 2023 $133 · 2024 $644 · 2025 $241

Food & beverage: $241
CompanyPaymentsAmount
Antares Pharma, Inc.4$84
Boehringer Ingelheim Pharmaceuticals, Inc.2$27
Saluda Medical Americas, Inc.1$22
Lilly USA, LLC1$19
Verity Pharmaceuticals Inc.1$16
ABBVIE INC.1$16
Bayer Healthcare Pharmaceuticals Inc.1$15
AstraZeneca Pharmaceuticals LP1$14
Novo Nordisk Inc1$14
Phathom Pharmaceuticals, Inc.1$13

Products named: XYOSTED, JARDIANCE, Evoke, MOUNJARO, Tlando, LINZESS, Kerendia, FARXIGA.

Industry payments across CA — which companies pay providers there.